130A:Veritas In Silico
Remove from History
Add to History
諸事情によりHistoryの登録はログインユーザーに限定。
Current:
338.0
PreviousClose:
337.0
Open:
331.0
High:
344.0
Low:
331.0
Dividend History None
EPS:
-96.79
BPS:
215.39
ROA:
-15.9%
ROE:
-36.7%
Veritas In Silico Inc. engages in the business of small molecule drug discovery and nucleic acid drug discovery targeting mRNA. The company has commercialization agreement with Liverpool ChiroChem for the mRNA-targeted drug discovery and development. Veritas In Silico Inc. was incorporated in 2016 and is based in Shinagawa, Japan.